The maintenance of glucose levels in the blood is primarily dependent on insulin, as well as other regulatory hormones. This system relies on the interplay of hormones, neural stimuli, cytokines, and other regulatory factors operating in various organs to keep plasma glucose under control.

The pancreatic beta cell plays a critical role in this complex system. In the fasting state, decreased insulin levels lead to the burning of fatty acids in fat tissues, making them a key energy source.

The liver uses these fatty acids for producing glucose during prolonged fasting. However, the brain requires glucose, necessitating alternative energy sources during fasting.

The liver provides glucose during extended fasting. The pancreas releases glucagon during fasting, promoting gluconeogenesis and glycogenolysis in the liver, thus maintaining glucose levels in the blood.

In the post-meal state, the pancreatic beta cell senses glucose, triggering the release of insulin. Insulin then performs several metabolic functions, such as reducing hepatic glucose production, promoting glucose absorption in peripheral tissues, and decreasing lipolysis in fat tissues.

The impacts of insulin on various tissues, including skeletal muscle, adipose tissue, and liver, are explored below. Skeletal muscle primarily utilizes glucose and free fatty acids for energy during the post-meal and fasting states, respectively. Skeletal muscle is the main site of glucose absorption after a meal, with insulin being primarily responsible for this function.

An increase in blood glucose following a meal is detected by pancreatic beta cells, which then release insulin. Insulin then initiates a signaling process that results in the transport of the glucose transporter 4 GLUT 4 to the plasma membrane of the skeletal muscle.

GLUT-4 then facilitates glucose absorption by the muscle. After entering skeletal muscle cells, glucose is converted by the hexokinase enzyme into glucosephosphate, which can either be stored as glycogen or used in the glycolytic pathway.

A significant portion of glucose in this pathway is oxidized to produce energy, with a small amount being converted into lactate.

During fasting, decreased insulin levels limit the hormone's anti-lipolytic effects in white fat tissue. This leads to increased lipolysis in the tissue and the generation of fatty acids, which serve as the main fuel source for skeletal muscle. The liver acts as the main source of glucose production during fasting, ensuring that cells reliant on glucose, such as neurons, red blood cells, and renal medulla cells, function optimally.

This is achieved by increasing glycogenolysis, gluconeogenesis, and glycogen synthesis in the period following absorption. This system relies on the interaction of hormones, substrates, and allosteric factors, the details of which are beyond the scope of this discussion.

During the period following a meal, insulin facilitates several actions that diminish the liver's glucose production. The insulin receptor IR consists of two distinct parts: an external component made up of two alpha subunits, and a part that crosses the cell membrane, which includes two beta subunits.

In typical bodily functions, the alpha subunits suppress the inherent tyrosine kinase activity of the beta subunits. Upon binding with insulin, the alpha subunit of the IR experiences a reduction in its capacity to restrain the beta subunit.

As a result, when insulin binds to the IR, it encourages the phosphorylation of internal proteins necessary for various subsequent signaling processes in different tissues.

The activation of the insulin receptor leads to various effects within the cell, including the enhanced synthesis of glycogen, protein, and lipids.

Meanwhile, lipolysis and gluconeogenesis processes are curtailed. Additionally, insulin encourages the mobilization of glucose transporter channels on peripheral tissues, such as skeletal muscle.

A significant part of our comprehension of chronic high blood sugar in individuals with type 2 diabetes is insulin resistance. This condition is defined by the inability of regular insulin levels in the blood to lower glucose levels during the post-meal state.

Consequently, enhanced liver glucose production, increased lipolysis, and compromised peripheral glucose uptake contribute to high blood sugar. Insulin therapy can either complement or be the primary treatment for managing type 2 diabetes.

However, insulin treatment is essential to prevent dangerous ketoacidosis in patients with either structural or functional issues with the pancreas such as type 1 diabetes. Even though backed by clinical evidence, the recommendations for insulin use in type 2 diabetes differ substantially among various clinical practice guidelines.

It is commonly agreed upon, though, that insulin is initiated in patients likely to experience beta cell failure and worsening high blood sugar, even when taking optimized doses of non-insulin therapies. Patients with type 1 diabetes need both basal and mealtime insulin if they are on multiple daily insulin injections.

The standard initial total daily insulin dose is 0. Patients with good carbohydrate counting abilities may use a carbohydrate ratio to estimate the amount of bolus insulin. The MyEndoconsult Team.

A group of physicians dedicated to endocrinology and internal medicine education. Please log in again. The login page will open in a new tab. After logging in you can close it and return to this page. My Endo Consult Accessibility Statement.

We firmly believe that the internet should be available and accessible to anyone, and are committed to providing a website that is accessible to the widest possible audience, regardless of circumstance and ability. These guidelines explain how to make web content accessible to people with a wide array of disabilities.

Complying with those guidelines helps us ensure that the website is accessible to all people: blind people, people with motor impairments, visual impairment, cognitive disabilities, and more.

This website utilizes various technologies that are meant to make it as accessible as possible at all times. Additionally, the website utilizes an AI-based application that runs in the background and optimizes its accessibility level constantly.

As soon as a user with a screen-reader enters your site, they immediately receive a prompt to enter the Screen-Reader Profile so they can browse and operate your site effectively.

In this process, we provide screen-readers with meaningful data using the ARIA set of attributes. For example, we provide accurate form labels; descriptions for actionable icons social media icons, search icons, cart icons, etc. It will also extract texts that are embedded within the image, using an OCR optical character recognition technology.

Screen-reader users also get automatic announcements to turn the Screen-reader mode on as soon as they enter the website.

The background process also handles triggered popups by moving the keyboard focus towards them as soon as they appear, and not allow the focus drift outside of it. We aim to support the widest array of browsers and assistive technologies as possible, so our users can choose the best fitting tools for them, with as few limitations as possible.

Despite our very best efforts to allow anybody to adjust the website to their needs, there may still be pages or sections that are not fully accessible, are in the process of becoming accessible, or are lacking an adequate technological solution to make them accessible.

Still, we are continually improving our accessibility, adding, updating and improving its options and features, and developing and adopting new technologies.

All this is meant to reach the optimal level of accessibility, following technological advancements. For any assistance, please reach out to admin myendoconsult. Mechanism of Action of Insulin. Share 0. Tweet 0. Pin 0. Basic Science Physiology of Insulin Action Insulin's Composition Insulin is a hormone composed of 51 amino acids, forming two chains—A and B—interlinked by a pair of disulfide bonds.

Blood Glucose Regulation The maintenance of glucose levels in the blood is primarily dependent on insulin, as well as other regulatory hormones. Glucose Metabolism Fasting State. Glucose Metabolism Fed State. Insulin's Impact on Different Tissues Skeletal muscle primarily utilizes glucose and free fatty acids for energy during the post-meal and fasting states, respectively.

Trending Adrenal Washout Calculator. Trending Orchidometer. Mechanism of action of insulin. Mechanism of Action of Insulin A significant part of our comprehension of chronic high blood sugar in individuals with type 2 diabetes is insulin resistance. Insulin resistance in type 2 diabetes manifests differently in various tissues: In skeletal muscle, there is a problem with the transportation of the glucose transporter 4 GLUT4 to the cell membrane of muscle cells and a defect in the tyrosine phosphorylation of several insulin receptor substrates.

This leads to a decrease in glucose uptake by the skeletal muscle. There are several different types of insulin. Your doctor will work with you to:. Your doctor will take several factors into consideration to determine which type of insulin is right for you. For instance, they will look at:.

Some manufacturers also sell premixed insulin that combines rapid or short-acting insulin with intermediate-acting insulin. Your healthcare professional will help you choose the right size syringe and can teach you how and when to inject yourself with insulin.

Insulin is an important hormone that helps your body use, store, and regulate the glucose sugar in your blood. The most common condition associated with insulin is diabetes. People with type 1 diabetes need to take insulin every day. Lifestyle changes and oral medications can manage type 2 diabetes, but insulin is sometimes needed.

Some begin to work quickly and last a few hours. Others take longer to start working but can last for up to 24 hours. Our experts continually monitor the health and wellness space, and we update our articles when new information becomes available. Insulin is a lifesaving medication for people with diabetes, and access to affordable insulin is imperative.

Using insulin can be tricky sometimes. Here are some do's and don'ts to pay attention to as you learn how to effectively manage your diabetes with…. Insulin resistance doesn't have to turn into diabetes. Know about early signs and find out what you can do to identify the condition.

The three P's of diabetes refer to the most common symptoms of the condition. Those are polydipsia, polyuria, and polyphagia. High blood glucose can…. Singer Nick Jonas, who has type 1 diabetes, debuted a new blood glucose monitoring device during a Super Bowl television commercial.

Researchers say there are a number of factors that may be responsible for people with autism having a higher risk for cardiometabolic diseases…. A Quiz for Teens Are You a Workaholic? How Well Do You Sleep? Health Conditions Discover Plan Connect.

What to Know About How Insulin Works. Medically reviewed by Stella Bard, MD — By S. Srakocic on January 21, About insulin Insulin and diabetes Symptoms Diagnosis Treatment Types of insulin How to use Summary Your body produces a wide range of hormones to help control many important functions.

What is insulin and what does it do? What are the symptoms of insulin not working properly? Result A1C level standard range below 5.

Insulin treatment. Types of insulin. Ways to use insulin. The bottom line. How we reviewed this article: Sources. Healthline has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical associations.

We avoid using tertiary references. You can learn more about how we ensure our content is accurate and current by reading our editorial policy. Jan 21, Written By S.

You have to inject insulin into the fat under your skin for it to get to your bloodstream. You cannot take it as a pill because it would get broken down during the process of digestion, which would make it much less effective than it needs to be. People with type 2 diabetes who can manage their condition with lifestyle changes and other medications might not need to use insulin.

There are several different types of insulin. Your doctor will work with you to:. Your doctor will take several factors into consideration to determine which type of insulin is right for you. For instance, they will look at:. Some manufacturers also sell premixed insulin that combines rapid or short-acting insulin with intermediate-acting insulin.

Your healthcare professional will help you choose the right size syringe and can teach you how and when to inject yourself with insulin. Insulin is an important hormone that helps your body use, store, and regulate the glucose sugar in your blood.

The most common condition associated with insulin is diabetes. People with type 1 diabetes need to take insulin every day. Lifestyle changes and oral medications can manage type 2 diabetes, but insulin is sometimes needed.

Some begin to work quickly and last a few hours. Others take longer to start working but can last for up to 24 hours.

Our experts continually monitor the health and wellness space, and we update our articles when new information becomes available. Insulin is a lifesaving medication for people with diabetes, and access to affordable insulin is imperative. Using insulin can be tricky sometimes.

Here are some do's and don'ts to pay attention to as you learn how to effectively manage your diabetes with…. Insulin resistance doesn't have to turn into diabetes. Know about early signs and find out what you can do to identify the condition.

The three P's of diabetes refer to the most common symptoms of the condition. Those are polydipsia, polyuria, and polyphagia.

High blood glucose can…. Singer Nick Jonas, who has type 1 diabetes, debuted a new blood glucose monitoring device during a Super Bowl television commercial. Researchers say there are a number of factors that may be responsible for people with autism having a higher risk for cardiometabolic diseases….

A Quiz for Teens Are You a Workaholic? How Well Do You Sleep? Health Conditions Discover Plan Connect. What to Know About How Insulin Works. Medically reviewed by Stella Bard, MD — By S.

Srakocic on January 21, About insulin Insulin and diabetes Symptoms Diagnosis Treatment Types of insulin How to use Summary Your body produces a wide range of hormones to help control many important functions. What is insulin and what does it do? What are the symptoms of insulin not working properly?

Result A1C level standard range below 5. Insulin treatment. Types of insulin. Ways to use insulin. The bottom line. How we reviewed this article: Sources. Healthline has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical associations.

In clinical research, scientists and physicians have explored different strategies to prevent and treat diabetes mellitus and IR. gov to reduce IR and summarized them mainly include: 1 Diet intervention, such as Low-fat vegetarian Food, high-protein food, calorie restriction, vitamin D supplementation to reduce the IR in human obesity.

We present some clinical trials of IR intervention in Table 2. Over the past years, our knowledge of the pathogenesis of IR and T2DM has improved, the development of new treatments of IR and metabolic syndrome have gained certain success, while the complexity of IR and the presence of multiple feedback loops make a challenge to the specific intervention.

In recent years, accumulating preclinical studies on the intervention of IR have been reported, which have important reference significance for the development of new drugs.

We present the related studies on IR reported in recent years in Table 3 , including animal models, treatment methods and results. Pre-clinical IR intervention mainly includes drug intervention, probiotic therapy and exercise supplement.

Drug therapy to improve IR is the main research direction at present. Researchers found that Valdecoxib VAL can inhibit inflammation and endoplasmic reticulum ER stress through AMPK-regulated HSPB1 pathway, thus improving skeletal muscle IR under hyperlipidemia.

The researchers found that the mixed nasal administration of GLP-1 receptor agonist and L-form of peneracin can effectively alleviate the cognitive dysfunction of SAMP8 mice.

Natividad et al. Regular exercise is an alternative intervention measure to maintain the blood sugar level in the normal range and reduce the risk factors. Hsu and colleagues found that exercise combined with probiotics intervention can have a positive effect on blood sugar and increase insulin sensitivity in mice.

The above results show that drug intervention, probiotic supplementation and intensive exercise can improve IR but more clinical data are still needed. Overall, the increased incidence of IR and the key roles of IR plays in many diseases, urgently require a better understanding of IR pathogenesis in addition to how IR interacts with genetics and different environments.

A deeper understanding of IR can be achieved with a more systematic approach involving large-scale omics to study the molecular landscape is of major importance in addition to exploring new intervention strategies to prevent abnormal IR syndrome.

Banting, F. The internal secretion of the pancreas. Indian J. CAS PubMed Google Scholar. SANGER, F. The amino-acid sequence in the glycyl chain of insulin. The identification of lower peptides from partial hydrolysates. Biochem J. Article CAS PubMed PubMed Central Google Scholar.

The investigation of peptides from enzymic hydrolysates. Kung, Y. Total synthesis of crystalline bovine insulin. Goeddel, D. et al. Expression in Escherichia coli of chemically synthesized genes for human insulin.

USA 76 , — Vecchio, I. The discovery of insulin: an important milestone in the history of medicine. Front Endocrinol. Article Google Scholar.

Cheatham, B. Insulin action and the insulin signaling network. Root, H. Insulin resistance and bronze diabetes. Laakso, M. Insulin resistance and hyperglycaemia in cardiovascular disease development.

Article CAS PubMed Google Scholar. Bugianesi, E. Insulin resistance in nonalcoholic fatty liver disease. Saklayen, M. The global epidemic of the metabolic syndrome. Diamanti-Kandarakis, E. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Stenvers, D. Circadian clocks and insulin resistance. Article PubMed CAS Google Scholar. Freeman AM, Pennings N. Insulin Resistance. In: StatPearls Internet. Treasure Island FL : StatPearls Publishing. PMID: American Diabetes Association. Prevention or delay of type 2 diabetes: standards of medical care in diabetes Diabetes Care 44 , S34—S39 Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes Diabetes Care 44 , S—S Weiss, M.

Insulin biosynthesis, secretion, structure, and structure-activity relationships. In: Feingold KR, Anawalt B, Boyce A, et al. South Dartmouth MA : MDText. com, Inc. Sanger, F. Chemistry of insulin. Science , — Katsoyannis, P. Synthesis of insulin.

Lee, J. The insulin receptor: structure, function, and signaling. Pessin, J. Signaling pathways in insulin action: molecular targets of insulin resistance.

Invest , — Haeusler, R. Biochemical and cellular properties of insulin receptor signalling. Cell Biol. White, M. Mechanisms of insulin action. In Atlas of diabetes pp.

Springer, Boston, MA Newgard, C. Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase Diabetes 49 , — Beurel, E. Glycogen synthase kinase-3 GSK3 : regulation, actions, and diseases.

Article CAS Google Scholar. Dong, X. Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab. Puigserver, P.

Insulin-regulated hepatic gluconeogenesis through FOXO1—PGC-1α interaction. Nature , — Vander Haar, E. Garami, A. Cell 11 , — Laplante, M. mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis.

USA , — Han, Y. Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene. Calejman, C. mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis.

Xia, W. Loss of ABHD15 impairs the anti-lipolytic action of insulin by altering PDE3B stability and contributes to insulin resistance. Cell Rep. James, D. The aetiology and molecular landscape of insulin resistance. Tam, C. Defining insulin resistance from hyperinsulinemic-euglycemic clamps.

Diabetes care 35 , — Samuel, V. Mechanisms for insulin resistance: common threads and missing links. Cell , — Ye, J.

Mechanisms of insulin resistance in obesity. Front Med. Article PubMed PubMed Central Google Scholar. Yaribeygi, H.

Insulin resistance: Review of the underlying molecular mechanisms. Cell Physiol. De Meyts, P. The insulin receptor: a prototype for dimeric, allosteric membrane receptors? Trends Biochem Sci. Caro, J.

Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. Invest 79 , — Fröjdö, S. Alterations of insulin signaling in type 2 diabetes: a review of the current evidence from humans.

Biochim Biophys. Acta , 83—92 Fisher, S. Michael, M. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Cell 6 , 87—97 Davis, R. The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser Article PubMed Google Scholar.

Carvalho-Filho, M. Diabetes 54 , — Taniguchi, C. Critical nodes in signalling pathways: insights into insulin action. Brachmann, S. Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice.

Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. CAS PubMed PubMed Central Google Scholar. Czech, M. Signaling mechanisms that regulate glucose transport.

Luo, J. Loss of class IA PI3K signaling in muscle leads to impaired muscle growth, insulin response, and hyperlipidemia. Cong, L. Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Xia, J. Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis.

Le Marchand-Brustel, Y. Insulin receptor tyrosine kinase is defective in skeletal muscle of insulin-resistant obese mice. Brozinick, J. Defective signaling through Akt-2 and-3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance.

Diabetes 52 , — Kruszynska, Y. Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation.

Choi, K. Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Korean J. Intern Med. Kahn, B. Glucose transport: pivotal step in insulin action.

Diabetes 45 , — Dimitriadis, G. Insulin effects in muscle and adipose tissue. Diabetes Res Clin. Shepherd, P.

Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. Li, J. Reduced glucose uptake precedes insulin signaling defects in adipocytes from heterozygous GLUT4 knockout mice.

FASEB J. Klip, A. Recruitment of GLUT-4 glucose transporters by insulin in diabetic rat skeletal muscle. Biochem Biophys. Res Commun. Etgen, G. Jr et al. Exercise training reverses insulin resistance in muscle by enhanced recruitment of GLUT-4 to the cell surface.

Ryder, J. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin-and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients.

Garvey, W. Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes: heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters.

Diabetes 42 , — Chadt, A. Deletion of both Rab-GTPase—activating proteins TBC14KO and TBC1D4 in mice eliminates insulin-and AICAR-stimulated glucose transport. Diabetes 64 , — Chen, S. Tramunt, B. Sex differences in metabolic regulation and diabetes susceptibility.

Diabetologia 63 , — Greenhill, C. Sex differences in insulin resistance. Qiu, J. Estradiol protects proopiomelanocortin neurons against insulin resistance. Endocrinology , — Zidon, T. Effects of ERβ and ERα on OVX-induced changes in adiposity and insulin resistance.

Ikeda, K. Functions of estrogen and estrogen receptor signaling on skeletal muscle. Steroid Biochem Mol. Gerdts, E. Sex differences in cardiometabolic disorders. Chia, C. Age-related changes in glucose metabolism, hyperglycemia, and cardiovascular risk. Shi, H. Sex differences in obesity-related glucose intolerance and insulin resistance.

Glucose Tolerance 4 , 37—66 Google Scholar. Geer, E. Gender differences in insulin resistance, body composition, and energy balance. Christen, T. Sex differences in body fat distribution are related to sex differences in serum leptin and adiponectin.

Peptides , 25—31 Palmisano, B. Sex differences in lipid and lipoprotein metabolism. Kodama, K. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis.

Diabetes Care 36 , — Raygor, V. Diab Vasc. Sumner, A. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis , — Tan, V. Ethnic differences in insulin sensitivity and beta-cell function among Asian men.

Diabetes 5 , e—e Ministry of Health Singapore MOHS. Potts, J. Sex and ethnic group differences in fat distribution in young United Kingdom South Asians and Europids. Ehtisham, S. Ethnic differences in insulin resistance and body composition in United Kingdom adolescents.

Lear, S. Ethnic variation in fat and lean body mass and the association with insulin resistance. Mason, C. Dietary weight loss and exercise effects on insulin resistance in postmenopausal women.

Med 41 , — Mikusova, V. Insulin resistance and need for a lifestyle change to eliminate it. Listy , — orpeleijn, E. Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle.

Shigeta, H. Lifestyle, obesity, and insulin resistance. Diabetes Care 24 , Oosterman, J. The circadian clock, shift work, and tissue-specific insulin resistance. Endocrinology , bqaa McAuley, K. Intensive lifestyle changes are necessary to improve insulin sensitivity: a randomized controlled trial.

Diabetes care 25 , — Bergman, B. Novel and reversible mechanisms of smoking-induced insulin resistance in humans. Diabetes 61 , — Kan, C. A systematic review and meta-analysis of the association between depression and insulin resistance.

Diabetes care 36 , — Sung, C. Role of vitamin D in insulin resistance. Ardabili, H. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.

Pasieka, A. Impact of glucocorticoid excess on glucose tolerance: clinical and preclinical evidence. Metabolites 6 , 24 Article PubMed Central CAS Google Scholar. Rizza, R. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action.

Effects of growth hormone on insulin action in man: mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31 , — Barbour, L. A Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes.

Diabetes Care 30 , S—S Parichatikanond, W. Prolonged stimulation of β2-adrenergic receptor with β2-agonists impairs insulin actions in H9c2 cells. Walli, R. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIVinfected patients.

AIDS 12 , F—F Murata, H. The mechanism of insulin resistance caused by HIV protease inhibitor therapy. Teff, K. Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease.

Diabetes 62 , — Bittencourt, M. Insulin therapy in insulin resistance: could it be part of a lethal pathway? Elbein, S. Heritability of pancreatic beta-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds.

Shulman, G. Cellular mechanisms of insulin resistance. Knauf, C. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.

Petersen, M. Regulation of hepatic glucose metabolism in health and disease. Matsumoto, M. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism.

Shimomura, I. Cell 6 , 77—86 Petersen, K. Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.

Henriksen, E. Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Drug Targets 7 , — Karim, S. Hepatic expression and cellular distribution of the glucose transporter family. World J. Rencurel, F. Requirement of glucose metabolism for regulation of glucose transporter type 2 GLUT2 gene expression in liver.

Thorens, B. Diabetologia 58 , — Eberlé, D. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86 , — Horton, J. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.

Ferré, P. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes. Tobe, K. Dentin, R. Carbohydrate responsive element binding protein ChREBP and sterol regulatory element binding protein-1c SREBP-1c : two key regulators of glucose metabolism and lipid synthesis in liver.

Biochimie 87 , 81—86 Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. Herman, M. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Iizuka, K. Deficiency of carbohydrate response element-binding protein ChREBP reduces lipogenesis as well as glycolysis.

Natl Acad. Jaworski, K. Regulation of triglyceride metabolism. Hormonal regulation of lipolysis in adipose tissue. Liver Physiol. Vaughan, M. Hormone-sensitive lipase and monoglyceride lipase activities in adipose tissue. Zmuda-Trzebiatowska, E. Role of PDE3B in insulin-induced glucose uptake, GLUT-4 translocation and lipogenesis in primary rat adipocytes.

Cell Signal 18 , — Choi, Y. Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B—null mice.

Martinez-Botas, J. Genet 26 , — Tansey, J. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. USA 98 , — Mechanisms of Insulin Action and Insulin Resistance.

Kimball, S. Regulation of protein synthesis by insulin. Pösö, A. Multifunctional control of amino acids of deprivation-induced proteolysis in liver.

Role of leucine. Marshall, S. New insights into the metabolic regulation of insulin action and insulin resistance: role of glucose and amino acids.

Rudrappa, S. Human skeletal muscle disuse atrophy: effects on muscle protein synthesis, breakdown, and insulin resistance-a qualitative review. Front Physiol. Medeiros, C. Antuna-Puente, B. Adipokines: the missing link between insulin resistance and obesity.

Diabetes Metab. Rabe, K. Adipokines and insulin resistance. Adipokines mediate inflammation and insulin resistance. Lausanne 4 , 71 Li, S. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA , — Hotta, K. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.

Diabetes 50 , — Takahashi, M. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett. Yamauchi, T.

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Li, L. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Diabetes , — Soriguer, F.

Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Yue, P. Apelin is necessary for the maintenance of insulin sensitivity. American journal of physiology. Apelin decreases lipolysis via G q , G i , and AMPK-dependent mechanisms. Endocrinology , 59—68 Segal, K.

Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Amitani, M. The role of leptin in the control of insulin-glucose axis. Front Neurosci. Article PubMed PubMed Central CAS Google Scholar. Ceddia, R. Analysis of paradoxical observations on the association between leptin and insulin resistance.

Covey, S. The pancreatic beta cell is a key site for mediating the effects of leptin on glucose homeostasis. Seufert, J. Leptin effects on pancreatic beta-cell gene expression and function. Diabetes 53 , S—S Myers, M. Mechanisms of leptin action and leptin resistance.

Burguera, B. Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Gainsford, T. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells.

USA 93 , — Scherer, P. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55 , — Saponaro, C.

The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis. Nutrients 7 , — Frayn, K. Adipose tissue and the insulin resistance syndrome. Roden, M. Mechanism of free fatty acid-induced insulin resistance in humans.

Invest 97 , — Goossens, G. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. RANDLE, P. The glucose fatty-acid cycle.

Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1 , — Randle, P. The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Y Acad. Brechtel, K. Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic 1H-MRS study.

Reson Med 45 , — Boden, G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46 , 3—10 Rothman, D. USA 92 , — Cline, G. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes.

Dresner, A. Effects of free fatty acids on glucose transport and IRSassociated phosphatidylinositol 3-kinase activity.

Yu, C. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 IRS-1 -associated phosphatidylinositol 3-kinase activity in muscle. Erion, D. Diacylglycerol-mediated insulin resistance. Kim, J. PKC-theta knockout mice are protected from fat-induced insulin resistance.

Nagai, Y. The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance.

Yen, C. The triacylglycerol synthesis enzyme DGAT1 also catalyzes the synthesis of diacylglycerols, waxes, and retinyl esters. Lipid Res. Timmers, S. Muscular diacylglycerol metabolism and insulin resistance. Liu, L. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance.

Sokolowska, E. The Role of Ceramides in Insulin Resistance. Lausanne 10 , Schubert, K. Chaurasia, B. Trends Endocrinol. Stiban, J. Ceramide synthases: roles in cell physiology and signaling.

Med Biol. Stöckli, J. Metabolomic analysis of insulin resistance across different mouse strains and diets. Blachnio-Zabielska, A. The crucial role of CCer in fat-induced skeletal muscle insulin resistance. Biochem 40 , — Raichur, S. CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance.

Turpin, S. Obesity-induced CerS6-dependent C ceramide production promotes weight gain and glucose intolerance. Holland, W. An FGFadiponectin-ceramide axis controls energy expenditure and insulin action in mice.

Mente, A. Causal relationship between adiponectin and metabolic traits: a Mendelian randomization study in a multiethnic population.

PLoS One 8 , e Brown, A. Genetics of Insulin Resistance and the Metabolic Syndrome. Chen, Z. Functional Screening of Candidate Causal Genes for Insulin Resistance in Human Preadipocytes and Adipocytes. Shakhanova, A. Association of polymorphism genes LPL , ADRB2 , AGT and AGTR1 with risk of hyperinsulinism and insulin resistance in the Kazakh population.

Henkin, L. Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Parks, B. Genetic architecture of insulin resistance in the mouse. Xue, A. Genome-wide association analyses identify risk variants and putative regulatory mechanisms for type 2 diabetes.

Yousef, A. IRS-1 genetic polymorphism r. Appl Clin. Genet 11 , 99— Hashemian, L. The role of the PPARG Pro12Ala common genetic variant on type 2 diabetes mellitus risk. Zeng, Q. Association Between Insulin-like Growth Factor-1 rs Polymorphism and Type 2 Diabetes Mellitus Susceptibility: A Meta-Analysis.